Adme Project Leadership for Genetic Medicines

Eli Lilly Eli Lilly · Pharma · Boston, MA

This role focuses on ADME (Absorption, Distribution, Metabolism, and Excretion) and DMPK (Drug Metabolism and Pharmacokinetics) studies to support the preclinical and clinical development of genetic medicines at Eli Lilly. The scientist will lead studies, interpret data, collaborate with multidisciplinary teams, and contribute to regulatory communications. The role requires a Ph.D. and experience in ADME or PK/PD within the pharmaceutical/biotechnology industry.

What you'd actually do

  1. Lead and innovate in a multidisciplinary team environment with primary responsibility for ADME studies to support preclinical and clinical development of the Lilly genetic medicines portfolio
  2. Design, implement, and interpret hypothesis-driven studies to inform key ADME, PK/PD, and toxicokinetic (TK) questions
  3. Integrate ADME, PK and PK/PD endpoints with discovery chemistry and biology data to guide preclinical drug design, optimization, and delivery strategies.
  4. Lead the preparation of ADME portions of regulatory communications and documents to support clinical development, new drug applications, and line extensions and interact with global regulatory authorities
  5. Mentor and support junior scientists and build relationships through coaching and mentorship with fellow scientists at all levels

Skills

Required

  • Ph.D. in Biochemistry/Biology/Pharmacokinetics/Bioengineering/Pharmacology or a related scientific field
  • Greater than five years of experience as a scientist in a pharmaceutical and/or biotechnology company in a role related to ADME or PK/PD
  • High learning agility
  • Ability to articulate and efficiently test ADME and DMPK hypotheses
  • Strong working knowledge in fundamental pharmaceutics, pharmacokinetics/pharmacodynamics, and ADME principles
  • Understanding of pharmaceutical regulatory guidance and expectations
  • Agile interrogation of diverse data (in silico, in vitro, in vivo)
  • Excellent written and verbal technical communication

Nice to have

  • Knowledge of DMPK and/or bioanalytical considerations for gene editing therapeutics
  • Experience with PK/PD modeling and simulation
  • Experience with targeted delivery and biodistribution of oligonucleotides and/or gene therapies
  • Understanding of and experience with PCR, immunoassay, and/or LC/MS bioanalytical methodology

What the JD emphasized

  • Strong working knowledge in fundamental pharmaceutics, pharmacokinetics/pharmacodynamics, and ADME principles - especially as they relate to novel genetic medicine therapeutic modalities
  • Understanding of pharmaceutical regulatory guidance and expectations
  • Agile interrogation of diverse data (e.g., in silico, in vitro, in vivo) to interpret complex data sets and to derive mechanistic understanding of drug action and ADME/DMPK characteristics